We are a Pre-clinical Medical Device Company Specializing in

Transfemoral Mitral Valve Repair

for the treatment of Degenerative Mitral Regurgitation

We Focus

on the comprehensive treatment of degenerative mitral valve disease, a leading cause of mitral regurgitation, by utilizing advanced non-surgical techniques.

Our Goal

is the percutaneous treatment of degenerative mitral regurgitation with a novel medical device that respects and expalnds upon the proven principles of mitral valve surgery.

What is Mitral Regurgitation?

Mitral regurgitation (MR) is the abnormal reverse flow of blood due to leakage through the mitral valve during each heartbeat. A common heart valve disease, MR affects about 5% of Western populations, and approximately 1% of patients will require medical treatment. MR can be caused by an abnormal mitral valve, called degenerative MR (DMR), preferably treated with valve repair.
We have the solution to fill the very large unmet clinical need for DMR patients

Vesalius’ Critical Mission

To provide a safe and non-invasive treatment for all DMR patients by creating an innovative and reliable medical device that save lives

Degenerative Mitral Regurgitation (DMR) Statistics

0 %

of all people

0 %

of people over 70

0 M

cases in 2023

0 %

Mortality rate within 5yrs

Our Solution's Advantages

Contact Us For More Info

Our Transfemoral Repair for Degenerative Mitral Regurgitation represents a transformative advancement in heart disease treatment. If you’d like to learn more about this life-saving technology, please get in touch. You are not only contributing to better patient outcomes, but also getting involved with a rapidly growing market. Join us in revolutionizing heart care and seeing the benefits of a healthier future for millions.

latest news

News & Articles